COMBINATION THERAPY FOR TREATING CANCER
First Claim
1. A method for treating cancer in a patient in need thereof comprising administering (i) a therapeutically effective amount of an EZH2 inhibitor and a therapeutically effective amount of a standard of care agent, (ii) a therapeutically effective amount of a combination comprising an EZH2 inhibitor and a standard of care agent, or (iii) a therapeutically effective amount of a composition comprising an EZH2 inhibitor and a standard of care agent.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
-
Citations
27 Claims
- 1. A method for treating cancer in a patient in need thereof comprising administering (i) a therapeutically effective amount of an EZH2 inhibitor and a therapeutically effective amount of a standard of care agent, (ii) a therapeutically effective amount of a combination comprising an EZH2 inhibitor and a standard of care agent, or (iii) a therapeutically effective amount of a composition comprising an EZH2 inhibitor and a standard of care agent.
-
2-3. -3. (canceled)
-
7. (canceled)
-
10. (canceled)
-
23. (canceled)
-
25. (canceled)
Specification